Campbell Soup Co.'s stock edges up as it beats Wall Street profit and revenue estimates
By Steve Gelsi
Food company warns its sales are tracking at lower end of forecast
Campbell Soup Co.'s stock rose Wednesday after the food company's revenue and adjusted second-quarter profit beat analyst estimates, but it said its 2024 performance is currently tracking at the low end of its sales guidance range.
Campbell Soup's (CPB) net income for the three months ended Jan. 28 fell to $203 million, or 68 cents a share, from $232 million, or 77 cents a share, in the year-ago quarter.
Adjusted profit of 80 cents a share beat the FactSet consensus estimate of 77 cents a share. Second-quarter revenue fell 1% to $2.46 billion, ahead of the analyst estimate of $2.44 billion.
Campbell Soup's stock moved up by 0.2% on Wednesday morning.
Looking ahead, Campbell reiterated its guidance from Aug. 31 for its expected financial performance in 2024 but added a note of caution.
"Full-year top-line growth rate is currently tracking to the lower end of the net sales guidance range, with possible upside should the pace of consumer recovery accelerate in the second half of the year," the company said.
In August, Campbell said it expected 2024 sales to either fall by about 0.5% or increase by up to 1.5%.
Analysts currently expect 2024 sales of $9.35 billion, down slightly from $9.36 billion in 2023.
Campbell said it expects to complete its acquisition of Sovos Brands Inc. in the week of March 11.
The company announced the $2.7 billion all cash deal for the parent of Rao's pasta sauces in August.
Prior to Wednesday's moves, the stock has fallen 18% in the last 12 months, while the S&P 500 SPX has gained 25%.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-06-24 1022ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks